Contact Us

Next-Generation Antibody Therapeutics Market Insights 2025: Size, Share, Trends & Strategic Forecast

16 May, 2025

The Next-Generation Antibody Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Next-Generation Antibody Therapeutics Market?

The market size for next-generation antibody therapeutics has seen a significant growth in the recent past. It was projected to increase from $6.82 billion in 2024 to $7.63 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Next-Generation Antibody Therapeutics Industry?

The Next-Generation Antibody Therapeutics Global Market is projected to expand to a market size of $11.52 billion by 2029. This growth will occur at a Compound Annual Growth Rate (CAGR) of 10.9%.

Download Your Free Sample of the 2025 Next-Generation Antibody Therapeutics Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Next-Generation Antibody Therapeutics Market?

The key drivers in the next-generation antibody therapeutics market are:

• Development of biosimilars, bispecific antibodies, and nanobodies
• Utilization of patient-centric approaches and immunomodulatory antibodies
• Increase in antibody applications in treating autoimmune diseases and adoption of continuous manufacturing
• Advancements in antibody engineering, digital technologies in antibody design, and drug delivery systems through industry collaborations and real-world evidence-based development.

Global Market Segmentation: Identifying Major Next-Generation Antibody Therapeutics Industry Segments

The next-generation antibody therapeutics market covered in this report is segmented –
1) By Types Of Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Biospecific Antibodies, Antibody-Drug Conjugates, Other Types
2) By Therapeutic Area: Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas
3) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Pre-order the 2025 Next-Generation Antibody Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!

What are the Emerging Trends Shaping the Future of the Next-Generation Antibody Therapeutics Market?

The key trends in the next-generation antibody therapeutics market are:

• Advancements in antibody engineering are expected to shape the future of the market.
• The use of digital technologies in antibody design is an emerging trend.
• Industry collaborations will significantly influence the future of next-generation antibody therapeutics.
• Advancements in drug delivery systems will play an integral role in the future of the market.

Who Are the Top Competitors & Leading Players in the Next-Generation Antibody Therapeutics Market?

The major players in the next-generation antibody therapeutics market are:

• Pfizer Inc

Regional Dominance: Which Area Leads the Global Next-Generation Antibody Therapeutics Market?

North America was the largest region in the next-generation antibody therapeutics market in 2024

Back to top WhatsApp icon